Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

View:
Post by Ingiboy on May 18, 2023 3:02pm

Arbitration

Well with just a few days left before the Arbitration 
it looks like there will be no pre Hearing deal before the Hearing. I imagine both sides are putting the final touches on their argument . Let's hope Replicel has a good one. This is like David  vs Goliath. I am not convinced this will go Replicel's way.  Regardless it will not be the end of the company.  It will just leave yet another Biotechnology company  with good technology and no working capital. 

Good luck  to all longs !
Comment by Year3000 on May 21, 2023 4:56pm
I really thought we would've heard something by now! Looks like it is going all the way to the arbitration.  Good luck to all! 
Comment by Ingiboy on May 22, 2023 12:46pm
7 days left....anything can happen.  We know according to Sedar that Replicel has reached out to Shiseido ( no confirmation this is true).  There could possibly be an ongoing discussion. On the other hand this may be put in the hands of the Arbitrator.    It will be interesting to see if in this final week of trading there are some gamblers willing to bet on Replicel.  If ...more  
Comment by Genie29j on May 22, 2023 4:06pm
It's definitely a defining moment for the company and our investments It's important Replicel wins, but: What does winning look like? If they get the Asia rights back, then what?  What happens if they win, and the results Shiseido did with their studies are less than ideal? (I.e. not as good as Phase 1). Then what? someething really positive needs to happen here. They can ...more  
Comment by BellEnd on May 22, 2023 11:58pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities